Clinical Trial

Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated April 12, 2022 (before its estimated February 10, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is single center, open-label phase I/II, non-randomized study which will enroll patients with recurrent advanced hepatocellular carcinoma to evaluate the safety, feasibility, and efficacy of fully human B7H3 CAR-T in treating hepatocellular carcinoma.
Trial Details
NCT Number NCT05323201
Lead Sponsor The Affiliated Hospital of Xuzhou Medical University
Collaborators: Xuzhou Medical University, IIT MediTech Co. Ltd
Conditions Hepatocellular Carcinoma
Enrollment 15 participants
Start Date 2022-02-10
Primary Completion 2024-02-10 (estimated)
Study Completion 2027-02-10 (estimated)
Updated on ClinicalTrials.gov 2022-04-12